A detailed history of Tocqueville Asset Management L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 4,190 shares of BIO stock, worth $1.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,190
Previous 3,555 17.86%
Holding current value
$1.39 Million
Previous $1.23 Million 6.92%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$268.26 - $339.48 $170,345 - $215,569
635 Added 17.86%
4,190 $1.14 Million
Q1 2024

May 09, 2024

BUY
$304.11 - $351.99 $270,657 - $313,271
890 Added 33.4%
3,555 $1.23 Million
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $717,871 - $972,831
2,665 New
2,665 $860,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.17B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.